Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Human Papillomavirus-Related Carcinoma × Human Papillomavirus Recombinant Vaccine nonavalent × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 6 Acquired Immunodeficiency Syndrome 2 Warts 1 Uterine Cervical Dysplasia 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Human Papillomavirus-Related Cervical Carcinoma 1 Human Papillomavirus-Related Carcinoma 1 Hematologic Neoplasms 1 HIV Infections 1 Condylomata Acuminata 1

Interventions

Specimen Handling 1 Human Papillomavirus Recombinant Vaccine nonavalent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05985681 2025-09-29

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

National Cancer Institute (NCI)

Phase 1 Recruiting

Human Papillomavirus-Related Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡